Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

587 Articles

Chris Lange | Jul 26, 2017 at 8:55 AM EDT

Major Pharma Short Interest Takes a Big Step Back

The July 14 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 21, 2017 at 8:37 AM EDT

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the…

Chris Lange | Jul 13, 2017 at 9:20 AM EDT

Major Pharma Short Sellers Become More Selective

The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 27, 2017 at 8:45 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jun 22, 2017 at 12:10 PM EDT

The Top 20 S&P 500 Companies Buying Back Stock in 2017

These are the top 20 stock buybacks in dollars spent during the first quarter of 2017 of all S&P 500…

Lee Jackson | Jun 12, 2017 at 10:10 AM EDT

4 Red-Hot Pharmaceutical and Biotechs Highlight Jefferies Top Stocks to Buy

A series of new reports from Jefferies focus on some of the top stocks in the pharmaceutical and biotech arenas.…

Chris Lange | Jun 12, 2017 at 8:55 AM EDT

Short Sellers Grow More Selective on Major Pharma

The May 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 6, 2017 at 1:25 PM EDT

Celldex Therapeutics Sinks Following ASCO Results

Celldex Therapeutics was another big mover coming out of the Annual Meeting for the American Society of Clinical Oncology (ASCO).…

Chris Lange | Jun 5, 2017 at 9:45 AM EDT

7 ASCO Stocks Moving on Cancer Study News (Updated)

The Annual Meeting for the American Society of Clinical Oncology (ASCO) is currently underway in Chicago, and the health care…

Chris Lange | Jun 2, 2017 at 1:35 PM EDT

15 Companies Bracing for Big ASCO Reactions

24/7 Wall St. takes a look at the ASCO annual meeting each year and picks out the companies that could…

Lee Jackson | May 25, 2017 at 10:15 AM EDT

Big Pharma Has Big Catalysts Coming for the Rest of 2017

A new Deutsche Bank research report focuses on the big capitalization pharmaceutical stocks and the upcoming catalysts and news flow…

Chris Lange | May 25, 2017 at 9:45 AM EDT

Major Pharma Short Interest Surges

The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Paul Ausick | May 15, 2017 at 11:35 AM EDT

Top Credit Suisse Pharma Picks Ahead of Catalysts

Credit Suisse provided its outlook for several large-cap pharmaceutical stocks Monday morning. The analyst has three top picks to consider.

Lee Jackson | May 12, 2017 at 8:25 AM EDT

Stock Market Looks Very Overbought: 5 Safe Stocks to Buy Now

Here are five good blue chip dividend stocks that are reasonably safe and offer good dividends, and they look good…

Trey Thoelcke | May 11, 2017 at 11:40 AM EDT

Why Big Pharma Is Not at Fault for Record Drug Spending

With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it…

1 … 18 19 20 21 22 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Major Pharma Short Interest Takes a Big Step Back

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Major Pharma Short Sellers Become More Selective

Short Sellers Run for Cover From Major Pharma

The Top 20 S&P 500 Companies Buying Back Stock in 2017

4 Red-Hot Pharmaceutical and Biotechs Highlight Jefferies Top Stocks to Buy

Short Sellers Grow More Selective on Major Pharma

Celldex Therapeutics Sinks Following ASCO Results

7 ASCO Stocks Moving on Cancer Study News (Updated)

15 Companies Bracing for Big ASCO Reactions

Big Pharma Has Big Catalysts Coming for the Rest of 2017

Major Pharma Short Interest Surges

Top Credit Suisse Pharma Picks Ahead of Catalysts

Stock Market Looks Very Overbought: 5 Safe Stocks to Buy Now

Why Big Pharma Is Not at Fault for Record Drug Spending

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

Prediction: Tesla Stock Will Hit $500 on This Date

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

Weirdly, the iPhone Might Be About to Become a Huge Drag on Apple’s Stock Price — or Maybe Not?

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Major Pharma Short Interest Takes a Big Step Back

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Major Pharma Short Sellers Become More Selective

Short Sellers Run for Cover From Major Pharma

The Top 20 S&P 500 Companies Buying Back Stock in 2017

4 Red-Hot Pharmaceutical and Biotechs Highlight Jefferies Top Stocks to Buy

Short Sellers Grow More Selective on Major Pharma

Celldex Therapeutics Sinks Following ASCO Results

7 ASCO Stocks Moving on Cancer Study News (Updated)

15 Companies Bracing for Big ASCO Reactions

Big Pharma Has Big Catalysts Coming for the Rest of 2017

Major Pharma Short Interest Surges

Top Credit Suisse Pharma Picks Ahead of Catalysts

Stock Market Looks Very Overbought: 5 Safe Stocks to Buy Now

Why Big Pharma Is Not at Fault for Record Drug Spending

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

Prediction: Tesla Stock Will Hit $500 on This Date

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge

Featured Reads

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

A 73 Year Old With $1.6 Million in a Traditional 401(k) Faces a $60,400 First RMD That Quietly Triggers an IRMAA Surcharge